Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Critical RiskFDA Drug
Medications & Supplements/Dietary Supplements

Bella All Natural: Bella Capsules Recalled for Undeclared Sibutramine

Agency Publication Date: March 5, 2018
Share:
Sign in to monitor this recall

Summary

Bella All Natural is recalling 32 bottles of Bella Capsules (600mg, 30-count) because they contain sibutramine, a weight-loss drug that was removed from the U.S. market in 2010 due to safety concerns. These capsules are considered unapproved drugs because their safety and effectiveness have not been proven. The affected products were sold in retail stores and online to customers in California. Consumers should immediately stop using these capsules and contact a healthcare provider or pharmacist regarding their health and potential refunds.

Risk

The undeclared sibutramine in these capsules can significantly increase blood pressure and heart rate, posing a serious risk to people with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. It may also interact in life-threatening ways with other medications a consumer might be taking.

What You Should Do

  1. Check your supplement bottles for 'Bella Capsules, 600mg, 30-count' manufactured for Bella All Natural.
  2. Verify the specific lot information on your bottle: look for Lot #: MFD:10.15.2017 with an expiration date of 10/14/2019.
  3. Stop taking these capsules immediately if you have a bottle from this specific lot.
  4. Contact your healthcare provider or pharmacist for guidance if you have consumed this product and have concerns about your health.
  5. Return any unused capsules to the place of purchase for a refund or contact Bella All Natural at their Los Angeles location for further instructions.
  6. Contact the FDA Consumer Complaint hotline for additional questions at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

💰Full Refund

Drug product refund and health guidance

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Bella Capsules (600mg, 30-count)
Model:
Recall #: D-0593-2018
Lot Numbers:
MFD:10.15.2017 (Exp. 10/14/2019)
Date Ranges: Expiration Date: 10/14/2019

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 79327
Status: Resolved
Manufacturer: Bella All Natural
Sold By: Retail stores; Online
Manufactured In: United States
Units Affected: 32 bottles
Distributed To: California

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.